default author photo

Kristine L. Keller

University of California, San Francisco (UCSF)

SCHOLARLY PAPERS

1

DOWNLOADS

49

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Remdesivir for Post-Exposure Prophylaxis of Marburg Virus Disease: A Retrospective Study Assessing Safety, Clinical, and Immunologic Outcome

Number of pages: 17 Posted: 16 Mar 2026
New York University (NYU) - New York University, Government of the Republic of Rwanda - Ministry of Health, Rwanda, Africa Health Sciences University, Africa Health Sciences University, University of California, San Francisco (UCSF), Government of the Republic of Rwanda - Ministry of Health, Rwanda, Rwanda Biomedical Center (RBC) - National Reference Laboratory Division, Rwanda Biomedical Center (RBC) - National Reference Laboratory Division, Rwanda Biomedical Center (RBC), Africa Health Sciences University, Rwanda Biomedical Center (RBC) - National Reference Laboratory Division, Africa Health Sciences University, King Faisal Hospital, Harvard University - Harvard Medical School, King Faisal Hospital, King Faisal Hospital, Africa Health Sciences University, Queen's University Belfast, Africa Health Sciences University, King Faisal Hospital, Africa Health Sciences University, Africa Health Sciences University, Africa Health Sciences University, King Faisal Hospital, Africa Health Sciences University, University of Rwanda, Africa Health Sciences University, Africa Health Sciences University, Rwanda Biomedical Center (RBC) - National Reference Laboratory Division, King Faisal Hospital, King Faisal Hospital, University of Rwanda, University of Rwanda, University of California, San Francisco (UCSF), Mekelle University, Africa Health Sciences University, Africa Health Sciences University, Government of the Republic of Rwanda - Ministry of Health, Rwanda, Government of the Republic of Rwanda - Ministry of Health, Rwanda and University of Wisconsin-Madison - School of Medicine and Public Health
Downloads 49 (1,109,210)

Abstract:

Loading...

Marburg Virus Disease, Remdesivir, Post-Exposure Prophylaxis (PEP), Viral Hemorrhagic Fever, Filoviruses